BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Ligilactobacillus salivarius {L. salivarius} - Escherichia coli NB8 |
👶
Effect of Lactobacillus salivarius on growth performance, diarrhea incidence, fecal bacterial population and intestinal morphology of suckling pigs challenged with F4+ enterotoxigenic Escherichia coli. Asian-Australasian journal of animal sciences (Asian-Australas J Anim Sci ) Vol: 31 Issue 8 Pages: 1308-1314 Pub: 2018 Aug Epub: 2018 Jun 21 Authors Sayan H , Assavacheep P , Angkanaporn K , Assavacheep A , Html Article Publication |
| Ligilactobacillus salivarius {L. salivarius} - Escherichia coli NB8 |
👶
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , Html Article Publication |
| Ligilactobacillus salivarius {L. salivarius} - Escherichia coli NB8 |
👶
Lactobacillus salivarius WZ1 Inhibits the Inflammatory Injury of Mouse Jejunum Caused by Enterotoxigenic Escherichia coli K88 by Regulating the TLR4/NF-?B/MyD88 Inflammatory Pathway and Gut Microbiota. Microorganisms (Microorganisms ) Vol: 11 Issue 3 Pages: Pub: 2023 Mar 3 Epub: 2023 Mar 3 Authors Wei Z , He Z , Wang T , Wang X , Wang T , Long M , Html Article Publication |
| Ligilactobacillus salivarius {L. salivarius} - Escherichia coli NB8 |
👶
Lactobacillus salivarius ameliorated Mycoplasma gallisepticum-induced inflammatory injury and secondary Escherichia coli infection in chickens: Involvement of intestinal microbiota. Veterinary immunology and immunopathology (Vet Immunol Immunopathol ) Vol: 233 Issue Pages: 110192 Pub: 2021 Mar Epub: 2021 Jan 15 Authors Wang J , Ishfaq M , Li J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
